Patents by Inventor Mae Counelis

Mae Counelis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amino glycoside antibiotics having antiprotozoal and anthelmintic activity
    Patent number: 4389398
    Abstract: In the fermentation production of gentamicin C a plurality of additional antibiotic compounds are obtained. Four of these compounds, gentamicin A, gentamicin B, gentamicin B.sub.1 and gentamicin X exhibit significant anti-protozoal and anthelmintic activity while gentamicin B and B.sub.1 have significant antibacterial properties with markedly reduced side affects.
    Type: Grant
    Filed: August 24, 1978
    Date of Patent: June 21, 1983
    Assignee: Schering Corporation
    Inventors: David J. Cooper, Jay A. Waitz, Mae Counelis, Jay Weinstein
  • Amino glycoside antibiotics having antiprotozoal activity
    Patent number: 4110439
    Abstract: In the fermentation production of gentamicin C a plurality of additional antibiotic compounds are obtained. Four of these compounds, gentamicin A, gentamicin B, gentamicin B.sub.1 and gentamicin X exhibit significant anti-protozoal and anthelmintic activity while gentamicin B and B.sub.1 have significant antibacterial properties with markedly reduced side effects.
    Type: Grant
    Filed: December 20, 1976
    Date of Patent: August 29, 1978
    Assignee: Schering Corporation
    Inventors: David J. Cooper, Jay A. Waitz, Mae Counelis, Jay Weinstein
  • Amino glycoside antibiotics having antibacterial activity
    Patent number: 4049796
    Abstract: In the fermentation production of gentamicin C a plurality of additional antibiotic compounds are obtained. Four of these compounds, gentamicin A, gentamicin B, gentamicin B.sub.1 and gentamicin X exhibit significant anti-protozoal and anthelmintic activity while gentamicin B and B.sub.1 have significant antibacterial properties with markedly reduced side effects.
    Type: Grant
    Filed: October 1, 1975
    Date of Patent: September 20, 1977
    Assignee: Schering Corporation
    Inventors: David J. Cooper, Jay Allan Waitz, Mae Counelis, Jay Weinstein